Tizanidine
- Product NDC
- 71335-3016
- 11-digit product format
- 713353016
- Labeler code
- 71335
- Product ID
- 71335-3016_f722dde4-55ee-44f4-9d1a-07214c62cd83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2003-12-11
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 313413 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-3016-1 | Tizanidine | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
| 71335-3016-2 | Tizanidine | 15 in 1 BOTTLE | TABLET | 15 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-3016-1 | 71335301601 | 90 TABLET in 1 BOTTLE (71335-3016-1) | 90 tablet | 2026-02-04 | No | No | Historical |
| 71335-3016-2 | 71335301602 | 15 TABLET in 1 BOTTLE (71335-3016-2) | 15 tablet | 2026-02-04 | No | No | Historical |